Kelso Pharma has a vision to bring innovative, value added, specialty medicines to the European healthcare markets that will provide meaningful benefits to patients and create added value for healthcare stakeholders. They plan to enhance value for the healthcare system by providing medicines that improve the lives of patients in a cost-effective way and are committed to behaving in an ethical manner in everything that they do.
Kelso Pharma, an emerging specialty pharma business came to use with a clean slate. They were looking for a logo, brand bible, website and other types of documentation to be created ahead of their acquisition of Stirling Anglian Pharmaceuticals.
We worked with them over the next month, researching and designing their logo, implementing and hosting their website, and creating a variety of documentation templates such such as a powerpoint, letterhead, etc.
We delivered the requirements in a record time and achieved our targets ahead of their acquisition. Their website and logo we created was able to be used by the press who reported the M&A headliner on the 12 January 2022.